Skip to main content

Table 1 Summary of recorded physiology

From: Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report

   

Pregnancy

 
 

Diagnosis PAH

3 months later

5th week

20th week

35th week

Delivery

3 months postpartum

NYHA

IV

III

III

III

III

III

IV

6-MWT m

229

423

454

396

276

 

392

RVSP mmHg (Echo)

69

 

normal

normal

40

 

57

SPAP mmHg

72

57

   

45

 

MPAP mmHg

52

35

   

21

 

PAOP mmHg

10

8

   

7

 

CI L/min/m2

1.3

3.4

   

4.3

 

PVR dyn.sec.cm−5

1580

410

   

250

 

mVO2%

35

67

   

69

 

SLEDAI [14]

17

2

2

  

14

18

Phenprocoumon (INR)

 

2.1

2.2

   

2.1

LMWH (Dalteparin E/day)

   

10,000

10,000

  

Prednisone (mg/day)

50

30

10

25

25

50

50

Hydroxychloroquine (mg/day)

200

200

200

200

200

200

200

Cyclophosphamide (mg/day)

100

100

     

Azathioprine (mg/day)

  

100

100

100

100

150

Bosentan (mg/day)

250

250

    

250

Sildenafil (mg/day)

150

150

150

150

150

150

150

Inhaled iloprost (μg/day)

    

50

100

 
  1. NYHA, New York Heart Association; 6-MWT, 6 minute walking test distance; RVSP, echocardiographic systolic right ventricular pressure over right atrial pressure; hemodynamic assessments by right heart catheterization: SPAP, systolic pulmonary arterial pressure; MPAP, mean pulmonary arterial pressure; PAOP, pulmonary arterial occlusive pressure; CI, cardiac index; PVR, pulmonary vascular resistance; mVO2, mixed venous oxygen saturation; SLEDAI, systemic lupus erythematosus disease activity index; LMWH, low molecular weight heparin.
Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947